Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Paramus NJ, New York NY, Bethlehem PA, Lancaster PA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for
Early Breast Cancer
Location: Ridgewood NJ, New York NY, Florham Park NJ, Jamaica NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05827081
Phase3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Paramus NJ, New York NY, Brooklyn NY, Lake Success NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Ridgewood NJ, The Bronx NY, Morristown NJ, Roslyn NY,
Sponsor: Edwards Lifesciences
Sex: All
Age: 65+
Code: NCT04889872
Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Location: Ridgewood NJ, New York NY, The Bronx NY, Mineola NY,
Sponsor: University of British Columbia
Sex: All
Age: 0+
Code: NCT04634240
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
for
Aortic Valve Insufficiency, Aortic Valve Stenosis
Location: Ridgewood NJ, New York NY, Morristown NJ,
Sponsor: Edwards Lifesciences
Sex: All
Age: 0+
Code: NCT05172973
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for
Primary Generalized Tonic-Clonic Seizures
Location: Hackensack NJ, Philadelphia PA, Baltimore MD,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 12+
Code: NCT05667142
Phase3, Recruiting
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
for
Seizures, Lennox Gastaut Syndrome
Location: Hackensack NJ, Philadelphia PA, Baltimore MD,
Sponsor: SK Life Science, Inc.
Sex: All
Age: 4 - 55
Code: NCT05219617
Phase3, Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy
for
KCNT1-Related Epilepsy
Location: Hackensack NJ
Sponsor: Actio Biosciences, Inc.
Sex: All
Age: 0 - 21
Code: NCT07600736
Phase2, Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Hackensack NJ, The Bronx NY, Philadelphia PA,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07563881
Phase3, Recruiting
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
for
GRIN-related Neurodevelopmental Disorder
Location: Hackensack NJ, New York NY, Philadelphia PA, Boston MA,
Sponsor: GRIN Therapeutics, Inc.
Sex: All
Age: 0 - 18
Code: NCT07224581
Phase3, Recruiting
Pediatric Vasculitis Initiative
for
Wegeners Granulomatosis (Granulomatosis With Polyangiitis),